RENAISSANCE TECHNOLOGIES LLC
Position in REGN — Regeneron Pharmaceuticals, Inc.
CIK 1037389
NEW YORK, NY
Position in REGN
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$92,422,345
+$40,808,448 QoQ
Shares Held
148,222
+121.9% QoQ
Ownership
0.144%
of shares outstanding
% of Portfolio
0.13%
of 13F equity value
Holder Rank
#87
of 1,322 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in REGN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026RENAISSANCE TECHNOLOGIES LLC holds $3,952,606,887 across 312 Biotechnology names. REGN ranks #9 (2.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | EXEL |
Exelixis, Inc.
|
13,427,993 | $730,617,099 | |
| 2 | CORT |
Corcept Therapeutics Inc
|
5,261,628 | $457,498,554 | |
| 3 | INCY |
Incyte Corp
|
3,512,132 | $398,135,283 | |
| 4 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
320,008 | $158,957,573 | |
| 5 | JAZZ |
Jazz Pharmaceuticals plc
|
562,073 | $135,442,730 | |
| 6 | RPRX |
Royalty Pharma plc
|
1,935,800 | $108,540,306 | |
| 7 | TVTX |
Travere Therapeutics, Inc.
|
1,833,079 | $104,137,217 | |
| 8 | GMAB |
Genmab A/S
|
3,517,850 | $96,635,339 |
All Filings in REGN
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $92,422,345 | 148,222 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $51,613,897 | 66,802 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $7,010,123 | 9,082 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $154,715,337 | 275,162 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $23,657,550 | 45,062 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $50,041,381 | 78,901 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $176,474,771 | 247,743 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $222,256,314 | 211,423 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $194,610,816 | 185,162 | Shares | Sole | 2024-08-09 | |
| 2024-03-31 | $159,159,271 | 165,362 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $213,478,923 | 243,062 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $133,370,543 | 162,062 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $63,375,228 | 88,200 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $94,409,883 | 114,900 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $138,122,767 | 191,441 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $143,560,508 | 208,400 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $344,665,440 | 583,062 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $195,461,218 | 279,862 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $178,696,162 | 282,962 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $61,281,737 | 101,262 | Shares | Sole | 2021-11-12 | |
| 2021-03-31 | $30,826,017 | 65,152 | Shares | Sole | 2021-05-13 | |
| 2020-12-31 | $437,191,360 | 904,952 | Shares | Sole | 2021-02-10 | |
| 2020-09-30 | $600,286,800 | 1,072,362 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $555,110,865 | 890,100 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $237,973,990 | 487,362 | Shares | Sole | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||